Dividend-focused exchange-traded funds (ETFs) have drawn renewed attention as investors weigh income generation, quality, and defensiveness against an evolving interest-rate and earnings backdrop. DLN and SCHD both target U.S. dividend-paying equities, yet they approach the same broad objective from fundamentally different angles. DLN captures dividend payers across the entire large-cap universe using a dividend-weighted methodology, giving it exposure to many of the market's largest growth names. SCHD instead applies a rigorous quality and dividend-sustainability screen before selecting high-yielding companies, producing a smaller, more value-oriented portfolio. Understanding their structural differences—rather than short-term price moves—is essential for investors deciding between broad-based dividend exposure and a focused, income-heavy strategy. I also checked this using Tickeron’s AI Screener to see how the two line up on key filters.
DLN is a passively managed fund that seeks to track the WisdomTree U.S. LargeCap Dividend Index. The index is dividend-weighted, meaning constituents are sized annually based on the projected aggregate cash dividends each company is expected to pay, rather than by market capitalization. This creates a portfolio of roughly 300 to 310 holdings spanning the large-cap dividend universe, with a heavy weighting toward mega-cap names. Top positions include MSFT, NVDA, JPM, AAPL, and XOM.
Sector allocation is led by technology (roughly 20–22%) and financials (roughly 18%), followed by healthcare, consumer staples, industrials, communication services, and energy. This tilt toward technology and financials gives DLN a growth-oriented character uncommon among traditional dividend funds. The fund carries an expense ratio of 0.28% and pays distributions on a monthly basis. Its large, diversified footprint and mega-cap concentration make it a broad, liquid proxy for dividend-paying U.S. large caps rather than a pure income vehicle.
SCHD is a passively managed fund that tracks the Dow Jones U.S. Dividend 100 Index. The underlying index applies a multi-step quality screen, selecting companies with a history of consistent dividend payments and sustainable payout fundamentals, then weighting the roughly 100 resulting names toward higher-yielding, financially strong businesses. Top holdings include QCOM, TXN, PG, KO, and MRK.
Sector exposure is concentrated in consumer staples (roughly 20%), healthcare (roughly 19–21%), technology (roughly 13–16%), and energy (roughly 15%), with smaller weights in financials and industrials. SCHD's expense ratio is just 0.06%, among the lowest in its category, and the fund pays distributions quarterly. Its defensive sector mix, quality screens, and substantial assets under management (AUM)—well over $100 billion—make it one of the most widely held dividend ETFs in the market, characterized by strong liquidity and lower historical volatility.
Both funds operate within the broader U.S. dividend-investing landscape, where income, quality, and valuation have re-emerged as key themes. Elevated interest rates have raised the appeal of cash-generating, dividend-paying businesses as a yield alternative, while a concentrated equity rally in mega-cap technology has kept growth-heavy strategies in the spotlight. For DLN, technology and financial sector earnings cycles are the primary performance drivers. For SCHD, the trajectory of consumer staples pricing, healthcare spending, and energy commodity trends plays a larger role. Regulatory scrutiny of large-cap technology and shifting expectations around Federal Reserve policy represent shared macro risks, though SCHD's value and income orientation historically provides a more defensive buffer during broad market drawdowns.
In recent weeks and market cycles, the two funds have reflected their distinct structural profiles. DLN's heavier technology exposure has allowed it to participate more directly in the momentum of mega-cap growth stocks, though this also introduces greater sensitivity to sector rotation and valuation pullbacks. SCHD, by contrast, has delivered steadier relative positioning, with its staples, healthcare, and energy emphasis providing ballast when growth leadership wavers. SCHD's lower beta indicates reduced sensitivity to broad market swings, while DLN's growth tilt can amplify both upside and downside. On an income basis, SCHD's higher distribution yield gives it a clear advantage for yield-seeking investors, while DLN's broader diversification and mega-cap weighting appeal to those prioritizing total-return potential and breadth. From what I see, the risk-adjusted edge leans defensive here.
When comparing funds like these, I often turn to Tickeron’s AI Screener to quickly filter on factors such as sector exposure, yield, volatility, and historical patterns. It surfaces data-driven insights that help put structural differences into context without manual number-crunching. The tool has become a regular part of my process for evaluating relative positioning across similar strategies.
Assessing structural strength, cost efficiency, diversification profile, trend consistency, sector momentum, and risk exposure, Tickeron's AI would currently favor SCHD. The fund's ultra-low 0.06% expense ratio, materially higher distribution yield, and disciplined quality screening offer a durable cost and income advantage, while its defensive sector mix and lower beta support more consistent, risk-adjusted positioning across market cycles. Although DLN's broader diversification and technology tilt may outperform during growth-led rallies, its higher cost, lower yield, and greater sensitivity to mega-cap concentration weigh on its relative appeal. This assessment reflects observable structural characteristics rather than a prediction of short-term returns and should not be interpreted as personalized investment advice.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day moving average for DLN crossed bearishly below the 50-day moving average on November 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DLN as a result. In 46 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for DLN turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 34 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
DLN moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where DLN advanced for three days, in 319 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
DLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 346 of 433 cases where DLN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows